Product Reports Resources Pricing Login Book a demo

Ultima Genomics

Health Tech & Medtech · Newark, United States · Founded 2016

Ultima Genomics is a pioneering company in the genomics industry, dedicated to advancing human health through innovative genomic sequencing technologies. The company operates in the high-throughput genomics market, which involves processing large volumes of genetic data to uncover insights into human biology and disease. Ultima Genomics serves a diverse range of clients, including academic researchers, pharmaceutical companies, and healthcare providers, who require comprehensive and precise genomic data for their work. The core of Ultima Genomics' business model is its revolutionary sequencing architecture, which significantly enhances the breadth, depth, and frequency of genomic data collection. "Breadth" refers to the ability to gather extensive data from each sample, "depth" means detecting even the smallest genetic variations, and "frequency" involves conducting routine tests for early disease detection and monitoring. By excelling in these areas, Ultima Genomics provides its clients with unparalleled access to high-quality genomic information. Ultima Genomics generates revenue by offering its advanced sequencing services and technologies to clients who need detailed genomic data for research and clinical applications. The company also partners with other organizations to drive forward the scale of genomic information, enabling groundbreaking discoveries and improvements in human health. By continuously innovating and expanding its capabilities, Ultima Genomics aims to help its customers achieve what was previously considered impossible in the field of genomics. In summary, Ultima Genomics is at the forefront of the genomics revolution, providing cutting-edge sequencing solutions that empower researchers and healthcare professionals to make significant strides in understanding and treating diseases. Keywords: Genomics, Sequencing, Biotechnology, Healthcare, Research, Innovation, Data, Technology, Health, DNA.

Valuation $1–2.5B
Revenue $100–500M
Headcount 100–500
Total funding $500M–1B
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Ultima Genomics and the history behind them.

Talent graph

Ultima Genomics's talent

Book a demo to see the people
Employees mapped 309 incl. 11 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 13 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

12 investors on Ultima Genomics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Khosla Ventures
Lightspeed Venture Partners
National Human Genome Research Institute
National Institutes of Health
Series B+ 8 investors entered at this stage

Global footprint

Where Ultima Genomics has talent and traffic

Workforce by country
7 countries with
team presence
🇺🇸 United States79.5%
🇮🇱 Israel15.8%
🇬🇧 United Kingdom1.9%
🇰🇷 South Korea0.8%
🇨🇦 Canada0.4%
Top 5 of 7 shown
Web traffic by country
9.7K monthly visits
across markets
🇺🇸 United States69.1%
🇮🇳 India14.4%
🇬🇧 United Kingdom7.2%
🇮🇱 Israel6.2%
🇮🇩 Indonesia2.1%
Top 5 markets shown

Patent intelligence

$33M patent portfolio · 67 active families

Estimated portfolio value
$33M
0.93% of valuation · 5.9× smaller than top peer Oxford Nanopore Technologies ($198M)
67 active patent families
Where Ultima Genomics innovates AnalyteBioinformaticsComputational biologyMolecular biologyNucleic acid molecule

Where Ultima Genomics concentrates vs peers

Each axis is a top-10 topic across Ultima Genomics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Ultima Genomics

An AI-synthesized read of the highest-engagement posts about Ultima Genomics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ultima Genomics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.